Heron Therapeutics (HRTX) Shares Outstanding (2016 - 2025)
Historic Shares Outstanding for Heron Therapeutics (HRTX) over the last 13 years, with Q3 2025 value amounting to $183.3 million.
- Heron Therapeutics' Shares Outstanding rose 2084.48% to $183.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $183.3 million, marking a year-over-year increase of 2084.48%. This contributed to the annual value of $152.1 million for FY2024, which is 122.63% up from last year.
- As of Q3 2025, Heron Therapeutics' Shares Outstanding stood at $183.3 million, which was up 2084.48% from $153.3 million recorded in Q2 2025.
- In the past 5 years, Heron Therapeutics' Shares Outstanding ranged from a high of $183.3 million in Q3 2025 and a low of $91.4 million during Q1 2021
- Its 5-year average for Shares Outstanding is $129.7 million, with a median of $120.0 million in 2023.
- Its Shares Outstanding has fluctuated over the past 5 years, first skyrocketed by 61.25% in 2022, then soared by 2636.13% in 2024.
- Over the past 5 years, Heron Therapeutics' Shares Outstanding (Quarter) stood at $102.0 million in 2021, then grew by 16.81% to $119.2 million in 2022, then increased by 26.13% to $150.3 million in 2023, then increased by 1.23% to $152.1 million in 2024, then increased by 20.51% to $183.3 million in 2025.
- Its Shares Outstanding stands at $183.3 million for Q3 2025, versus $153.3 million for Q2 2025 and $152.4 million for Q1 2025.